technetium has been researched along with Cystadenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackstein, ME; Kirsh, JC; Steinhardt, MI | 1 |
| Bomanji, J; Britton, KE; Burchell, J; Ellison, D; Granowska, M; Hudson, CR; Lowe, DG; Mather, SJ; Shepherd, JH; Taylor-Papadimitriou, J | 1 |
2 other study(ies) available for technetium and Cystadenocarcinoma
| Article | Year |
|---|---|
Multi-imaging demonstration of distant metastases from ovarian carcinoma.
Topics: Adult; Cystadenocarcinoma; Diphosphonates; Female; Humans; Ovarian Neoplasms; Radionuclide Imaging; Soft Tissue Neoplasms; Technetium; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 1984 |
Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.
Topics: Adult; Aged; Cystadenocarcinoma; Female; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Radioimmunodetection; Sensitivity and Specificity; Technetium | 1993 |